Form D · Other Technology
Veenome, Inc.
Arlington, VA · CIK 0001594568
Offering snapshot reported Jan 7, 2015 · SEC filing
- Reported sold
- $390K Offering amount: $679K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 17, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2015 | Initial | $389,970 | No comparison | 2 | SEC filing |
| Dec 19, 2013 | Initial | $1,930,000 | No comparison | 27 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-231560
Offer and sale of Convertible Promissory Notes and Warrant, and the underlying shares of Common Stock issuable upon conversion thereof.
Source: Form D, filed Jan 7, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Geller | Director |
| Kevin Lenane | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1400 Key Blvd. Suite 100
Arlington, VA, 22209
Arlington, VA, 22209